创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

唐琪, 赵贤省, 金亮. 脂肪来源基质血管组分治疗骨关节炎的临床研究进展[J]. 药学进展, 2021, 45(9): 685-696.
引用本文: 唐琪, 赵贤省, 金亮. 脂肪来源基质血管组分治疗骨关节炎的临床研究进展[J]. 药学进展, 2021, 45(9): 685-696.
TANG Qi, ZHAO Xiansheng, JIN Liang. Advances in Clinical Research on the Treatment of Osteoarthritis by Adipose-Derived Stromal Vascular Fraction[J]. Progress in Pharmaceutical Sciences, 2021, 45(9): 685-696.
Citation: TANG Qi, ZHAO Xiansheng, JIN Liang. Advances in Clinical Research on the Treatment of Osteoarthritis by Adipose-Derived Stromal Vascular Fraction[J]. Progress in Pharmaceutical Sciences, 2021, 45(9): 685-696.

脂肪来源基质血管组分治疗骨关节炎的临床研究进展

Advances in Clinical Research on the Treatment of Osteoarthritis by Adipose-Derived Stromal Vascular Fraction

  • 摘要: 骨关节炎(OA)是一种好发于中老年人的慢性关节疾病,临床主要表现为关节肿痛、僵硬和活动受限等,是致残的重要原因之一。基质血管组分(SVF)是脂肪组织除去成熟脂肪细胞等成分后的一种异质性细胞群,其中的间充质干细胞赋予SVF干细胞特性,其他多种细胞组分也具有调节机体免疫、促进组织重建等作用。通过对OA的流行病学、发病机制、诊断和治疗,以及SVF治疗OA的临床研究和其治疗机制进行综述,以期为SVF对OA的临床治疗研究提供参考。

     

    Abstract: Osteoarthritis (OA) is a chronic joint disease commonly occurring in middle-aged and elderly people, and is one of the important causes of disability, with such main clinical manifestations as joint swelling and pain, stiffness, and limited mobility. Stromal vascular fraction (SVF) is a heterogeneous cell population in adipose tissues without components such as mature adipocytes. Mesenchymal stem cells give SVF characteristics of stem cell, and various other cell components can regulate immunity and promote tissue reconstruction.This article reviews the epidemiology, pathogenesis, diagnosis and treatment of OA, as well as the clinical study and treatment mechanism of SVF for the treatment of OA in order to provide reference for the clinical treatment of osteoarthritis by stromal vascular fraction.

     

/

返回文章
返回